Literature DB >> 6098608

Cerebrovascular aspects of converting-enzyme inhibition I: Effects of intravenous captopril in spontaneously hypertensive and normotensive rats.

D I Barry, J O Jarden, O B Paulson, D I Graham, S Strandgaard.   

Abstract

The cerebrovascular effects of converting enzyme inhibition were examined in normotensive and hypertensive rats. Cerebral blood flow was measured using the intracarotid 133xenon injection method in halothane/nitrous oxide anaesthetized animals. The main finding was that following intravenous administration of captopril (10 mg/kg), cerebral blood flow autoregulation was markedly altered. Although cerebral blood flow was unchanged from baseline levels, both the lower and upper limits of autoregulation were reset to lower mean arterial pressure and the autoregulatory plateau shortened. The lower limit was shifted 20-30 mmHg, the upper limit 50-60 mmHg, and the plateau shortened by 20-40 mmHg. The effect was interpreted as being a consequence of compensatory autoregulatory constriction of small resistance vessels in the brain following captopril-induced dilatation of large resistance vessels. It was inferred that locally produced angiotensin II might play a role in the resistance of large cerebral arteries.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6098608     DOI: 10.1097/00004872-198412000-00003

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  12 in total

Review 1.  Angiotensin and cerebral blood flow.

Authors:  J M Saavedra; Y Nishimura
Journal:  Cell Mol Neurobiol       Date:  1999-10       Impact factor: 5.046

2.  Proceedings of the British Pharmacological Society Meeting. 3rd-5th January 1990. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

3.  Proceedings of the British Pharmacological Society Meeting. Sheffield, 18-20th April 1990.

Authors: 
Journal:  Br J Pharmacol       Date:  1990-06       Impact factor: 8.739

4.  Captopril improves cerebrovascular structure and function in old hypertensive rats.

Authors:  François Dupuis; Jeffrey Atkinson; Patrick Limiñana; Jean-Marc Chillon
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

Review 5.  Cerebral blood flow in the elderly: impact of hypertension and antihypertensive treatment.

Authors:  S Strandgaard
Journal:  Cardiovasc Drugs Ther       Date:  1991-01       Impact factor: 3.727

6.  Angiotensin converting enzyme inhibition, CBF autoregulation, and ICP in patients with normal-pressure hydrocephalus.

Authors:  J F Schmidt; A R Andersen; O B Paulson; F Gjerris
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

7.  Bradykinin antagonist counteracts the acute effect of both angiotensin-converting enzyme inhibition and of angiotensin receptor blockade on the lower limit of autoregulation of cerebral blood flow.

Authors:  Sigurdur T Sigurdsson; Olaf B Paulson; Arne Høj Nielsen; Svend Strandgaard
Journal:  J Cereb Blood Flow Metab       Date:  2013-12-11       Impact factor: 6.200

8.  Cerebral blood flow and metabolism during hypotension induced with sodium nitroprusside and captopril.

Authors:  L J Thomsen; S Riisager; K A Jensen; L Bünemann
Journal:  Can J Anaesth       Date:  1989-07       Impact factor: 5.063

Review 9.  Angiotensin converting enzyme inhibition and cerebral circulation--a review.

Authors:  G Waldemar; O B Paulson
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

10.  ACE (Angiotensin-Converting Enzyme) Inhibition Reverses Vasoconstriction and Impaired Dilation of Pial Collaterals in Chronic Hypertension.

Authors:  Zhaojin Li; Devon P Lindner; Nicole M Bishop; Marilyn J Cipolla
Journal:  Hypertension       Date:  2020-05-18       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.